Drugs News and Research

RSS

Researchers develop low-cost catnip mosquito repellent for rural Uganda

Plant researchers from Wales and Uganda have collaborated on a community enterprise project in rural Uganda, becoming the first to create affordable and highly effective mosquito repellent distilled from locally grown catnip plants.

7 Jul 2026

Study reveals why patients with rare leukemia develop resistance to tagraxofusp

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.

7 Jul 2026

New artificial intelligence model reveals invisible multiple sclerosis lesions

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be impacted has been mostly invisible to clinicians.

7 Jul 2026

HonorHealth offers new drug that doubles pancreatic cancer survival

Under an FDA ruling that expands access to clinical trials, HonorHealth Research Institute is one of the first in the nation to offer a new drug, Daraxonrasib, that based on early data nearly doubles the average survival time of patients with pancreatic cancer.

7 Jul 2026

Microbiome science merges with oncology for better cancer treatments

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.

7 Jul 2026

New EV-SELEX strategy accelerates drug discovery for wide range of GPCRs

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, which regulate diverse physiological processes ranging from pain perception to hormone signaling.

7 Jul 2026

New research reveals how dying bacteria force cell ejection

Popular science fiction is no stranger to escape pod scenarios, typically featuring characters who narrowly avoid their demise by jettisoning from a spaceship - think R2-D2 and C-3PO shooting away from a rebel spaceship in the opening of Star Wars: A New Hope. Biologists at the University of California San Diego have found that communities of bacteria feature a similar ejection capability.

7 Jul 2026

Single cocaine exposure causes lasting brain cell changes in mice

Researchers studying the impact of cocaine in mice have found that just one exposure to the drug can create changes in brain cells that persist for at least two weeks.

6 Jul 2026

New pair of techniques can speed up the search for better tuberculosis drugs

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) is the world's deadliest single-agent caused infection, responsible for 1.23 million deaths in 2024, according to the World Health Organization.

6 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

6 Jul 2026

Study reveals unexpected movement of drug-delivery swimming robots

One day, tiny swimming robots may travel through the human body to deliver drugs. The medication would target only areas of need-chemotherapy drugs for a tumor, for example-avoiding healthy tissue and minimizing side effects.

6 Jul 2026

McMaster researchers uncover why statins cause painful muscle side effects

Millions of people rely on statins - a medication used to lower cholesterol and reduce the risk of heart attack and stroke.

6 Jul 2026

Insilico Medicine highlights AI drug discovery progress at executive summit

Dr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7.

3 Jul 2026

New AI model improves prediction of cancer immunotherapy success

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

3 Jul 2026

Experimental drug shields nerve cells from damage caused by ALS

Amyotrophic Lateral Sclerosis, or ALS, received widespread awareness in the summer of 2014 thanks to an Ice Bucket Challenge. Millions of people participated in the challenge, drenching themselves in ice cold water to bring visibility to this devastating neurodegenerative disease and generate charitable donations for research.

3 Jul 2026

Can ibuprofen improve drug-resistant tuberculosis treatment?

While ibuprofen reduced inflammatory markers in drug-resistant TB patients, it did not enhance treatment outcomes, indicating the need for further research.

3 Jul 2026

Blocking nerve signaling may reduce cancer-associated cachexia

Researchers have uncovered a previously unrecognized pathway linking lung tumor genetics, diet, and the nervous system that drives cancer-associated cachexia, according to a new study in mice.

2 Jul 2026

New genome editing tool unlocks fungi's hidden drug-producing potential

Researchers have spent decades-and billions of dollars-sequencing animal and crop genomes, but fungi have historically been the forgotten middle child of genomics, only noticed when they're ruining bread or colonizing toes.

2 Jul 2026

Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.

2 Jul 2026

Insilico Medicine partners with Takeda for AI-driven drug discovery

Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas.

2 Jul 2026